Mechanisms of Fibroblast Activation during Fibrotic Tissue Remodeling
Fibrosis · 2024
DOI: 10.35534/fibrosis.2024.10002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fibrosis, 2024. Verfasst von Aleix Rius Rigau und 1 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 142 Literaturangaben.
Abstract (Originalsprache)
Fibrosis can occur in almost every organ system. It can occur in single organs, such as in idiopathic pulmonary fibrosis (IPF), or affect multiple organs as in systemic sclerosis (SSc). Fibrotic diseases are recognized as major cause of morbidity and mortality in modern societies due to the dysfunction or loss of function of the affected organs. This dysfunction is caused by progressive deposition of extracellular matrix proteins released by activated fibroblasts. Activation of fibroblasts and differentiation into myofibroblasts is required for physiological tissue remodeling, e.g, during wound healing. Disruption of regulatory mechanisms, however, results in chronic and uncontrolled activity of fibroblasts and myofibroblasts. Intensive research during the past years identified several core pathways of pathophysiological relevance, and described different fibroblast subsets based on their expression profile in fibrotic tissue. Herein, we discuss the molecular changes in fibroblasts leading to persistent activation during fibrotic tissue remodeling with a focus on lung fibrosis and SSc.
Zitieren
APA
Rigau, A. R., & Dees, C. (2024). Mechanisms of Fibroblast Activation during Fibrotic Tissue Remodeling. Fibrosis. https://doi.org/10.35534/fibrosis.2024.10002
Vancouver
Rigau AR, Dees C. Mechanisms of Fibroblast Activation during Fibrotic Tissue Remodeling. Fibrosis. 2024. doi:10.35534/fibrosis.2024.10002
BibTeX
@article{Rigau2024,
author = {Rigau, Aleix Rius and Dees, Clara},
title = {Mechanisms of Fibroblast Activation during Fibrotic Tissue Remodeling},
journal = {Fibrosis},
year = {2024},
doi = {10.35534/fibrosis.2024.10002}
}
EUVIMED